Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Afutuzumab Market Growth 2022-2028

  • LP 4974079
  • 121 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Afutuzumab will have significant change from previous year. According to our (LP Information) latest study, the global Afutuzumab market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Afutuzumab market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Afutuzumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Afutuzumab market, reaching US$ million by the year 2028. As for the Europe Afutuzumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Afutuzumab players cover BOC Sciences, Carbosynth, Roche Group, and TargetMol Chemicals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Afutuzumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Patent

Generic

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Chronic Lymphocytic Leukemia

Follicular Lymphoma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

BOC Sciences

Carbosynth

Roche Group

TargetMol Chemicals

Wonda Science

Absin Bioscience

Chunchuang (Wuhan) Technology

Hubei Kele Fine Chemical

Jiangxi Ruiweier Biotechnology

Qingdao Jieshikang Biotechnology

Shanghai Biochempartner

Shanghai Macklin Biochemical

Shanghai Qiming Biotechnology

Shanghai Saimai Biotechnology

Shanghai Shize Biological Technology

Shanghai Yifei Biotechnology

Shanghai Yu'ang Chemical

Tianmen Hengchang Chemical

Wuhan Sunrise Technology Development

Wuhan Yingnuo Pharmaceutical Technology

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Afutuzumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Afutuzumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Afutuzumab by Country/Region, 2017, 2022 & 2028

2.2 Afutuzumab Segment by Type

2.2.1 Patent

2.2.2 Generic

2.3 Afutuzumab Sales by Type

2.3.1 Global Afutuzumab Sales Market Share by Type (2017-2022)

2.3.2 Global Afutuzumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Afutuzumab Sale Price by Type (2017-2022)

2.4 Afutuzumab Segment by Application

2.4.1 Chronic Lymphocytic Leukemia

2.4.2 Follicular Lymphoma

2.5 Afutuzumab Sales by Application

2.5.1 Global Afutuzumab Sale Market Share by Application (2017-2022)

2.5.2 Global Afutuzumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Afutuzumab Sale Price by Application (2017-2022)

3 Global Afutuzumab by Company

3.1 Global Afutuzumab Breakdown Data by Company

3.1.1 Global Afutuzumab Annual Sales by Company (2020-2022)

3.1.2 Global Afutuzumab Sales Market Share by Company (2020-2022)

3.2 Global Afutuzumab Annual Revenue by Company (2020-2022)

3.2.1 Global Afutuzumab Revenue by Company (2020-2022)

3.2.2 Global Afutuzumab Revenue Market Share by Company (2020-2022)

3.3 Global Afutuzumab Sale Price by Company

3.4 Key Manufacturers Afutuzumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Afutuzumab Product Location Distribution

3.4.2 Players Afutuzumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Afutuzumab by Geographic Region

4.1 World Historic Afutuzumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Afutuzumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Afutuzumab Annual Revenue by Geographic Region

4.2 World Historic Afutuzumab Market Size by Country/Region (2017-2022)

4.2.1 Global Afutuzumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Afutuzumab Annual Revenue by Country/Region

4.3 Americas Afutuzumab Sales Growth

4.4 APAC Afutuzumab Sales Growth

4.5 Europe Afutuzumab Sales Growth

4.6 Middle East & Africa Afutuzumab Sales Growth

5 Americas

5.1 Americas Afutuzumab Sales by Country

5.1.1 Americas Afutuzumab Sales by Country (2017-2022)

5.1.2 Americas Afutuzumab Revenue by Country (2017-2022)

5.2 Americas Afutuzumab Sales by Type

5.3 Americas Afutuzumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Afutuzumab Sales by Region

6.1.1 APAC Afutuzumab Sales by Region (2017-2022)

6.1.2 APAC Afutuzumab Revenue by Region (2017-2022)

6.2 APAC Afutuzumab Sales by Type

6.3 APAC Afutuzumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Afutuzumab by Country

7.1.1 Europe Afutuzumab Sales by Country (2017-2022)

7.1.2 Europe Afutuzumab Revenue by Country (2017-2022)

7.2 Europe Afutuzumab Sales by Type

7.3 Europe Afutuzumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Afutuzumab by Country

8.1.1 Middle East & Africa Afutuzumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Afutuzumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Afutuzumab Sales by Type

8.3 Middle East & Africa Afutuzumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Afutuzumab

10.3 Manufacturing Process Analysis of Afutuzumab

10.4 Industry Chain Structure of Afutuzumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Afutuzumab Distributors

11.3 Afutuzumab Customer

12 World Forecast Review for Afutuzumab by Geographic Region

12.1 Global Afutuzumab Market Size Forecast by Region

12.1.1 Global Afutuzumab Forecast by Region (2023-2028)

12.1.2 Global Afutuzumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Afutuzumab Forecast by Type

12.7 Global Afutuzumab Forecast by Application

13 Key Players Analysis

13.1 BOC Sciences

13.1.1 BOC Sciences Company Information

13.1.2 BOC Sciences Afutuzumab Product Offered

13.1.3 BOC Sciences Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 BOC Sciences Main Business Overview

13.1.5 BOC Sciences Latest Developments

13.2 Carbosynth

13.2.1 Carbosynth Company Information

13.2.2 Carbosynth Afutuzumab Product Offered

13.2.3 Carbosynth Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Carbosynth Main Business Overview

13.2.5 Carbosynth Latest Developments

13.3 Roche Group

13.3.1 Roche Group Company Information

13.3.2 Roche Group Afutuzumab Product Offered

13.3.3 Roche Group Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Group Main Business Overview

13.3.5 Roche Group Latest Developments

13.4 TargetMol Chemicals

13.4.1 TargetMol Chemicals Company Information

13.4.2 TargetMol Chemicals Afutuzumab Product Offered

13.4.3 TargetMol Chemicals Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 TargetMol Chemicals Main Business Overview

13.4.5 TargetMol Chemicals Latest Developments

13.5 Wonda Science

13.5.1 Wonda Science Company Information

13.5.2 Wonda Science Afutuzumab Product Offered

13.5.3 Wonda Science Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Wonda Science Main Business Overview

13.5.5 Wonda Science Latest Developments

13.6 Absin Bioscience

13.6.1 Absin Bioscience Company Information

13.6.2 Absin Bioscience Afutuzumab Product Offered

13.6.3 Absin Bioscience Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Absin Bioscience Main Business Overview

13.6.5 Absin Bioscience Latest Developments

13.7 Chunchuang (Wuhan) Technology

13.7.1 Chunchuang (Wuhan) Technology Company Information

13.7.2 Chunchuang (Wuhan) Technology Afutuzumab Product Offered

13.7.3 Chunchuang (Wuhan) Technology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Chunchuang (Wuhan) Technology Main Business Overview

13.7.5 Chunchuang (Wuhan) Technology Latest Developments

13.8 Hubei Kele Fine Chemical

13.8.1 Hubei Kele Fine Chemical Company Information

13.8.2 Hubei Kele Fine Chemical Afutuzumab Product Offered

13.8.3 Hubei Kele Fine Chemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hubei Kele Fine Chemical Main Business Overview

13.8.5 Hubei Kele Fine Chemical Latest Developments

13.9 Jiangxi Ruiweier Biotechnology

13.9.1 Jiangxi Ruiweier Biotechnology Company Information

13.9.2 Jiangxi Ruiweier Biotechnology Afutuzumab Product Offered

13.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Jiangxi Ruiweier Biotechnology Main Business Overview

13.9.5 Jiangxi Ruiweier Biotechnology Latest Developments

13.10 Qingdao Jieshikang Biotechnology

13.10.1 Qingdao Jieshikang Biotechnology Company Information

13.10.2 Qingdao Jieshikang Biotechnology Afutuzumab Product Offered

13.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Qingdao Jieshikang Biotechnology Main Business Overview

13.10.5 Qingdao Jieshikang Biotechnology Latest Developments

13.11 Shanghai Biochempartner

13.11.1 Shanghai Biochempartner Company Information

13.11.2 Shanghai Biochempartner Afutuzumab Product Offered

13.11.3 Shanghai Biochempartner Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shanghai Biochempartner Main Business Overview

13.11.5 Shanghai Biochempartner Latest Developments

13.12 Shanghai Macklin Biochemical

13.12.1 Shanghai Macklin Biochemical Company Information

13.12.2 Shanghai Macklin Biochemical Afutuzumab Product Offered

13.12.3 Shanghai Macklin Biochemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shanghai Macklin Biochemical Main Business Overview

13.12.5 Shanghai Macklin Biochemical Latest Developments

13.13 Shanghai Qiming Biotechnology

13.13.1 Shanghai Qiming Biotechnology Company Information

13.13.2 Shanghai Qiming Biotechnology Afutuzumab Product Offered

13.13.3 Shanghai Qiming Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai Qiming Biotechnology Main Business Overview

13.13.5 Shanghai Qiming Biotechnology Latest Developments

13.14 Shanghai Saimai Biotechnology

13.14.1 Shanghai Saimai Biotechnology Company Information

13.14.2 Shanghai Saimai Biotechnology Afutuzumab Product Offered

13.14.3 Shanghai Saimai Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shanghai Saimai Biotechnology Main Business Overview

13.14.5 Shanghai Saimai Biotechnology Latest Developments

13.15 Shanghai Shize Biological Technology

13.15.1 Shanghai Shize Biological Technology Company Information

13.15.2 Shanghai Shize Biological Technology Afutuzumab Product Offered

13.15.3 Shanghai Shize Biological Technology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shanghai Shize Biological Technology Main Business Overview

13.15.5 Shanghai Shize Biological Technology Latest Developments

13.16 Shanghai Yifei Biotechnology

13.16.1 Shanghai Yifei Biotechnology Company Information

13.16.2 Shanghai Yifei Biotechnology Afutuzumab Product Offered

13.16.3 Shanghai Yifei Biotechnology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shanghai Yifei Biotechnology Main Business Overview

13.16.5 Shanghai Yifei Biotechnology Latest Developments

13.17 Shanghai Yu'ang Chemical

13.17.1 Shanghai Yu'ang Chemical Company Information

13.17.2 Shanghai Yu'ang Chemical Afutuzumab Product Offered

13.17.3 Shanghai Yu'ang Chemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Shanghai Yu'ang Chemical Main Business Overview

13.17.5 Shanghai Yu'ang Chemical Latest Developments

13.18 Tianmen Hengchang Chemical

13.18.1 Tianmen Hengchang Chemical Company Information

13.18.2 Tianmen Hengchang Chemical Afutuzumab Product Offered

13.18.3 Tianmen Hengchang Chemical Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Tianmen Hengchang Chemical Main Business Overview

13.18.5 Tianmen Hengchang Chemical Latest Developments

13.19 Wuhan Sunrise Technology Development

13.19.1 Wuhan Sunrise Technology Development Company Information

13.19.2 Wuhan Sunrise Technology Development Afutuzumab Product Offered

13.19.3 Wuhan Sunrise Technology Development Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Wuhan Sunrise Technology Development Main Business Overview

13.19.5 Wuhan Sunrise Technology Development Latest Developments

13.20 Wuhan Yingnuo Pharmaceutical Technology

13.20.1 Wuhan Yingnuo Pharmaceutical Technology Company Information

13.20.2 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offered

13.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview

13.20.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Afutuzumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Afutuzumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Patent

Table 4. Major Players of Generic

Table 5. Global Afutuzumab Sales by Type (2017-2022) & (Kg)

Table 6. Global Afutuzumab Sales Market Share by Type (2017-2022)

Table 7. Global Afutuzumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Afutuzumab Revenue Market Share by Type (2017-2022)

Table 9. Global Afutuzumab Sale Price by Type (2017-2022) & (US$/Kg)

Table 10. Global Afutuzumab Sales by Application (2017-2022) & (Kg)

Table 11. Global Afutuzumab Sales Market Share by Application (2017-2022)

Table 12. Global Afutuzumab Revenue by Application (2017-2022)

Table 13. Global Afutuzumab Revenue Market Share by Application (2017-2022)

Table 14. Global Afutuzumab Sale Price by Application (2017-2022) & (US$/Kg)

Table 15. Global Afutuzumab Sales by Company (2020-2022) & (Kg)

Table 16. Global Afutuzumab Sales Market Share by Company (2020-2022)

Table 17. Global Afutuzumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Afutuzumab Revenue Market Share by Company (2020-2022)

Table 19. Global Afutuzumab Sale Price by Company (2020-2022) & (US$/Kg)

Table 20. Key Manufacturers Afutuzumab Producing Area Distribution and Sales Area

Table 21. Players Afutuzumab Products Offered

Table 22. Afutuzumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Afutuzumab Sales by Geographic Region (2017-2022) & (Kg)

Table 26. Global Afutuzumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Afutuzumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Afutuzumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Afutuzumab Sales by Country/Region (2017-2022) & (Kg)

Table 30. Global Afutuzumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Afutuzumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Afutuzumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Afutuzumab Sales by Country (2017-2022) & (Kg)

Table 34. Americas Afutuzumab Sales Market Share by Country (2017-2022)

Table 35. Americas Afutuzumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Afutuzumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Afutuzumab Sales by Type (2017-2022) & (Kg)

Table 38. Americas Afutuzumab Sales Market Share by Type (2017-2022)

Table 39. Americas Afutuzumab Sales by Application (2017-2022) & (Kg)

Table 40. Americas Afutuzumab Sales Market Share by Application (2017-2022)

Table 41. APAC Afutuzumab Sales by Region (2017-2022) & (Kg)

Table 42. APAC Afutuzumab Sales Market Share by Region (2017-2022)

Table 43. APAC Afutuzumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Afutuzumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Afutuzumab Sales by Type (2017-2022) & (Kg)

Table 46. APAC Afutuzumab Sales Market Share by Type (2017-2022)

Table 47. APAC Afutuzumab Sales by Application (2017-2022) & (Kg)

Table 48. APAC Afutuzumab Sales Market Share by Application (2017-2022)

Table 49. Europe Afutuzumab Sales by Country (2017-2022) & (Kg)

Table 50. Europe Afutuzumab Sales Market Share by Country (2017-2022)

Table 51. Europe Afutuzumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Afutuzumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Afutuzumab Sales by Type (2017-2022) & (Kg)

Table 54. Europe Afutuzumab Sales Market Share by Type (2017-2022)

Table 55. Europe Afutuzumab Sales by Application (2017-2022) & (Kg)

Table 56. Europe Afutuzumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Afutuzumab Sales by Country (2017-2022) & (Kg)

Table 58. Middle East & Africa Afutuzumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Afutuzumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Afutuzumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Afutuzumab Sales by Type (2017-2022) & (Kg)

Table 62. Middle East & Africa Afutuzumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Afutuzumab Sales by Application (2017-2022) & (Kg)

Table 64. Middle East & Africa Afutuzumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Afutuzumab

Table 66. Key Market Challenges & Risks of Afutuzumab

Table 67. Key Industry Trends of Afutuzumab

Table 68. Afutuzumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Afutuzumab Distributors List

Table 71. Afutuzumab Customer List

Table 72. Global Afutuzumab Sales Forecast by Region (2023-2028) & (Kg)

Table 73. Global Afutuzumab Sales Market Forecast by Region

Table 74. Global Afutuzumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Afutuzumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Afutuzumab Sales Forecast by Country (2023-2028) & (Kg)

Table 77. Americas Afutuzumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Afutuzumab Sales Forecast by Region (2023-2028) & (Kg)

Table 79. APAC Afutuzumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Afutuzumab Sales Forecast by Country (2023-2028) & (Kg)

Table 81. Europe Afutuzumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Afutuzumab Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Middle East & Africa Afutuzumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Afutuzumab Sales Forecast by Type (2023-2028) & (Kg)

Table 85. Global Afutuzumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Afutuzumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Afutuzumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Afutuzumab Sales Forecast by Application (2023-2028) & (Kg)

Table 89. Global Afutuzumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Afutuzumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Afutuzumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. BOC Sciences Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 93. BOC Sciences Afutuzumab Product Offered

Table 94. BOC Sciences Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 95. BOC Sciences Main Business

Table 96. BOC Sciences Latest Developments

Table 97. Carbosynth Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 98. Carbosynth Afutuzumab Product Offered

Table 99. Carbosynth Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 100. Carbosynth Main Business

Table 101. Carbosynth Latest Developments

Table 102. Roche Group Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 103. Roche Group Afutuzumab Product Offered

Table 104. Roche Group Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 105. Roche Group Main Business

Table 106. Roche Group Latest Developments

Table 107. TargetMol Chemicals Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 108. TargetMol Chemicals Afutuzumab Product Offered

Table 109. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 110. TargetMol Chemicals Main Business

Table 111. TargetMol Chemicals Latest Developments

Table 112. Wonda Science Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 113. Wonda Science Afutuzumab Product Offered

Table 114. Wonda Science Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 115. Wonda Science Main Business

Table 116. Wonda Science Latest Developments

Table 117. Absin Bioscience Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 118. Absin Bioscience Afutuzumab Product Offered

Table 119. Absin Bioscience Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 120. Absin Bioscience Main Business

Table 121. Absin Bioscience Latest Developments

Table 122. Chunchuang (Wuhan) Technology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 123. Chunchuang (Wuhan) Technology Afutuzumab Product Offered

Table 124. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 125. Chunchuang (Wuhan) Technology Main Business

Table 126. Chunchuang (Wuhan) Technology Latest Developments

Table 127. Hubei Kele Fine Chemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 128. Hubei Kele Fine Chemical Afutuzumab Product Offered

Table 129. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 130. Hubei Kele Fine Chemical Main Business

Table 131. Hubei Kele Fine Chemical Latest Developments

Table 132. Jiangxi Ruiweier Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 133. Jiangxi Ruiweier Biotechnology Afutuzumab Product Offered

Table 134. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 135. Jiangxi Ruiweier Biotechnology Main Business

Table 136. Jiangxi Ruiweier Biotechnology Latest Developments

Table 137. Qingdao Jieshikang Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 138. Qingdao Jieshikang Biotechnology Afutuzumab Product Offered

Table 139. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 140. Qingdao Jieshikang Biotechnology Main Business

Table 141. Qingdao Jieshikang Biotechnology Latest Developments

Table 142. Shanghai Biochempartner Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 143. Shanghai Biochempartner Afutuzumab Product Offered

Table 144. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 145. Shanghai Biochempartner Main Business

Table 146. Shanghai Biochempartner Latest Developments

Table 147. Shanghai Macklin Biochemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 148. Shanghai Macklin Biochemical Afutuzumab Product Offered

Table 149. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 150. Shanghai Macklin Biochemical Main Business

Table 151. Shanghai Macklin Biochemical Latest Developments

Table 152. Shanghai Qiming Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 153. Shanghai Qiming Biotechnology Afutuzumab Product Offered

Table 154. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 155. Shanghai Qiming Biotechnology Main Business

Table 156. Shanghai Qiming Biotechnology Latest Developments

Table 157. Shanghai Saimai Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 158. Shanghai Saimai Biotechnology Afutuzumab Product Offered

Table 159. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 160. Shanghai Saimai Biotechnology Main Business

Table 161. Shanghai Saimai Biotechnology Latest Developments

Table 162. Shanghai Shize Biological Technology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 163. Shanghai Shize Biological Technology Afutuzumab Product Offered

Table 164. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 165. Shanghai Shize Biological Technology Main Business

Table 166. Shanghai Shize Biological Technology Latest Developments

Table 167. Shanghai Yifei Biotechnology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 168. Shanghai Yifei Biotechnology Afutuzumab Product Offered

Table 169. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 170. Shanghai Yifei Biotechnology Main Business

Table 171. Shanghai Yifei Biotechnology Latest Developments

Table 172. Shanghai Yu'ang Chemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 173. Shanghai Yu'ang Chemical Afutuzumab Product Offered

Table 174. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 175. Shanghai Yu'ang Chemical Main Business

Table 176. Shanghai Yu'ang Chemical Latest Developments

Table 177. Tianmen Hengchang Chemical Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 178. Tianmen Hengchang Chemical Afutuzumab Product Offered

Table 179. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 180. Tianmen Hengchang Chemical Main Business

Table 181. Tianmen Hengchang Chemical Latest Developments

Table 182. Wuhan Sunrise Technology Development Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 183. Wuhan Sunrise Technology Development Afutuzumab Product Offered

Table 184. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 185. Wuhan Sunrise Technology Development Main Business

Table 186. Wuhan Sunrise Technology Development Latest Developments

Table 187. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Afutuzumab Manufacturing Base, Sales Area and Its Competitors

Table 188. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offered

Table 189. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 190. Wuhan Yingnuo Pharmaceutical Technology Main Business

Table 191. Wuhan Yingnuo Pharmaceutical Technology Latest Developments

List of Figures

Figure 1. Picture of Afutuzumab

Figure 2. Afutuzumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Afutuzumab Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Afutuzumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Afutuzumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Patent

Figure 10. Product Picture of Generic

Figure 11. Global Afutuzumab Sales Market Share by Type in 2021

Figure 12. Global Afutuzumab Revenue Market Share by Type (2017-2022)

Figure 13. Afutuzumab Consumed in Chronic Lymphocytic Leukemia

Figure 14. Global Afutuzumab Market: Chronic Lymphocytic Leukemia (2017-2022) & (Kg)

Figure 15. Afutuzumab Consumed in Follicular Lymphoma

Figure 16. Global Afutuzumab Market: Follicular Lymphoma (2017-2022) & (Kg)

Figure 17. Global Afutuzumab Sales Market Share by Application (2017-2022)

Figure 18. Global Afutuzumab Revenue Market Share by Application in 2021

Figure 19. Afutuzumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Afutuzumab Revenue Market Share by Company in 2021

Figure 21. Global Afutuzumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Afutuzumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Afutuzumab Sales Market Share by Region (2017-2022)

Figure 24. Global Afutuzumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Afutuzumab Sales 2017-2022 (Kg)

Figure 26. Americas Afutuzumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Afutuzumab Sales 2017-2022 (Kg)

Figure 28. APAC Afutuzumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Afutuzumab Sales 2017-2022 (Kg)

Figure 30. Europe Afutuzumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Afutuzumab Sales 2017-2022 (Kg)

Figure 32. Middle East & Africa Afutuzumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Afutuzumab Sales Market Share by Country in 2021

Figure 34. Americas Afutuzumab Revenue Market Share by Country in 2021

Figure 35. United States Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Afutuzumab Sales Market Share by Region in 2021

Figure 40. APAC Afutuzumab Revenue Market Share by Regions in 2021

Figure 41. China Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Afutuzumab Sales Market Share by Country in 2021

Figure 48. Europe Afutuzumab Revenue Market Share by Country in 2021

Figure 49. Germany Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Afutuzumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Afutuzumab Revenue Market Share by Country in 2021

Figure 56. Egypt Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Afutuzumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Afutuzumab in 2021

Figure 62. Manufacturing Process Analysis of Afutuzumab

Figure 63. Industry Chain Structure of Afutuzumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390